License Agreement with Forte Animal Health, Inc. (Details Narrative) - USD ($) |
9 Months Ended | |
---|---|---|
Sep. 30, 2022 |
Jun. 30, 2022 |
|
Notes payable | $ 375,000 | |
Stock issued during period, shares | 81,615,483 | |
Forte Animal Health, Inc. [Member] | ||
Stock issued during period, shares | 2,235,000 | |
Equity method investment, ownership percentage | 15.00% | |
Forte Animal Health, Inc. [Member] | Amended License Agreement [Member] | ||
Notes payable | $ 1,775,275 | |
Interest payable | $ 264,790 | |
Forte Animal Health, Inc. [Member] | Amended License Agreement [Member] | Other Vendor and Employee [Member] | ||
Interest payable | $ 1,125,086 |
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of interest payable on debt, including, but not limited to, trade payables. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount for notes payable (written promise to pay), due to related parties. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|